SPDR Series Trust SPDR S&P Biotech ETF
Telah dikemas kini

Rolled: XBI February 18th 132 Short Call to the 110

134
... for a 1.64 credit.

Comments: Rolled the 132 down to what was the 25 delta strike on side test, after which the underlying promptly bounced back to 103 and change. I originally collected 2.69 (See Post Below) with a 50% max take profit at 1.34, so am revising my take profit to the original take profit of 1.34 plus what I received for this roll -- 1.64 (i.e., 2.98).
Nota
Rolling the 110 short call down to the 97 for a 2.16 credit, resulting in a 3-wide inversion (the 97C/100P). Total credits collected of 6.49.
Dagangan aktif
Rolling the February 18th 100P/97C out to the March 18th 93C/99P for a 1.93 credit. Total credits collected of 8.42 with a cost basis of 90.58 if assigned on the 99's.
Dagangan aktif
Selling the March 18th 71 short put for a 1.41 credit. Total credits collected of 9.83. Cost basis of 89.17 if assigned on the 99's. This illustrates one of the reasons why you don't go max deployed on margin. There will be times when you'll want to defend or rapidify cost basis reduction, and you'll need buying power available to do so.

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.